News Secretive Moderna could finally go public with $500m IPO RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.
News UK biotech Orchard plans $172.5m US IPO to fund rare disease... UK biotech Orchard Therapeutics is planning a US IPO to expand use of its Strimvelis gene therapy, and further develop its rare disease pipeline.
News UK biotech riding on crest of VC funding wave - report Venture capital funding for the UK biotech sector is robust following a solid start to the year, according to new data.
News Cancer blood test firm Grail mulls IPO Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
News Apitope announces IPO to fund MS drug development Biotech Apitope plans to float on the Brussels stock exchange to raise funds to develop a potential new MS drug.
News Biofrontera mulls US IPO to fund skin cancer drug German biotech Biofrontera is considering a US stock market listing to fund development and marketing of a skin cancer drug.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.